Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Oncology|October 5, 2022
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor EntitiesFranziska Erlmeier, Na Sun, Jian Shen, et al.Journal of Cancer|September 14, 2020
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High AccuracyMark Kriegsmann, Rita Casadonte, Nadine Maurer, et al.Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.The Journal of Pathology|May 13, 2015
High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samplesAchim Buck, Alice Ly, Benjamin Balluff, et al.European Urology|April 8, 2023
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic EvolutionAlexander Cox, Niklas Klümper, Johannes Stein, et al.Nature Protocols|July 15, 2016
High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissueAlice Ly, Achim Buck, Benjamin Balluff, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.European Urology|November 13, 2022
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint InhibitionFranziska Erlmeier, Niklas Klümper, Laura Landgraf, et al.Cancer Immunology Research|April 17, 2019
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer SubtypesCarolin Pfannstiel, Pamela L Strissel, Katherine B Chiappinelli, et al.Pathology, Research and Practice|February 18, 2022
The prognostic impact of Claudin 6 in papillary renal cell carcinomaMarie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, et al.Pageof 4